IL2 and melanoma: CD8+ T cells were isolated from the peripheral blood mononuclear cells (PBMCs) of 16 melanoma patients and activated with CD3/CD28/IL-2 stimulation, with CD45+/CD3+/CD8+ cells identified as the CD8+ T-cell population (Figure S13B).